Figure 5. Allergic patients have increased circulating MDSCs.

Symptomatic allergic patients were compared with nonallergic controls. Cells were isolated from peripheral blood gating strategy, presented in Supplemental Fig. 5. Percent total MDSCs (B) and subpopulations, CD14⁺ (C) or CD15⁺ (D), were determined by flow cytometry. (A) Representative allergic patient versus control and (B–D) compiled.*P < 0.05. Mean ± sd. Allergic patients, n = 6; controls, n = 6.